Vaccinology - Vaccine formulations Flashcards

1
Q

Which types of vaccine are considered ‘classic’? (3)

A

Vaccines that are based on the modification of a wild-type pathogen
1. Live-attenuated vaccines
2. Inactivated vaccines
3. Subunit vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which type of vaccine are considered ‘novel’? (5)

A

Vaccines that rely on recombinant DNA technologies
1. DNA vaccines
2. Vector-based vaccines
3. Virus-like particles
4. Antigen-loading of autologous DCs
5. RNA/mRNA vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are examples of current live-attenuated vaccines? (5)

A
  1. Measles, mumps, rubella (MMR/BMR)
  2. Varicella zoster virus (VZV)
  3. Yellow fever (YFV)
  4. Influenza
  5. BCG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which two production strategies can be used to produce live attenuated vaccines?

A
  1. Taking an animal pathogen similar to the human pathogen to generate cross-protection
  2. Adapt the virus to conditions very dissimilar in humans, ensuring that it can no longer effectively replicate in humans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are requirements of animal viruses being used to induce cross-protectivity against human viruses? (2)

A
  1. It must generate strong cross-protection
  2. The animal pathogen must have some replication in humans to induce an immune response, but not so much that it causes disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is an example of a succesful case of an animal virus being used to generate cross-protectivity against the human virus?

A

Cowpox being used for smallpox eradication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is an example of a virus that was passaged in conditions dissimilar to humans, making int unable to replicate efficiently in humans? Under which conditions was it adapted?

A

Rubella -> passaged in embryonated chicken eggs at reduced temperature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the advantages of live attenuated vaccines? (2)

A
  1. Immune responses resemble natural immunity
  2. Often induce long-lasting protection after a single dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why do live attenuated vaccines strongly mimic natural immunity?

A

Viral replication & antigen production within host cells leads to presentation on MHCI and MHCII, inducing a strong B- and T-cell (both CD4+ and CD8+) response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the disadvantages of live attenuated vaccines? (3)

A
  1. Safety risk in immunocompromised
  2. Possibility to revert to wildtype
  3. Interference by maternal antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are two reasons live attenuated vaccines cannot be given during the first few months of children’s life?

A
  1. Maternal antibodies neutralize the virus before it has a chance to trigger the immune system
  2. Immunodeficiencies have not always been diagnosed at a very young age -> live attenuated viruses could cause severe illness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

From how many months onwards are children typically vaccinated with live attenuated vaccines?

A

> 14 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the advantage of inactivated vaccines over live attenuated vaccines?

A

Infectivity & replication eliminated (no chance of spread or disease) while maintaining immunogenicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are examples of current inactivated vaccines? (4)

A
  1. Influenza (being replaced by subunit vaccines)
  2. Polio
  3. Hepatitis A
  4. Bordetella pertussis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are strategies to inactivate a virus for vaccines? (3)

A
  1. Chemicals (formalin)
  2. Heat (mild)
  3. Radiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are important characteristics for possible inactivation methods to produce an inactivated vaccine? (2)

A
  1. Antigenicity should be retained
  2. Immunogenicity should be retained
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the main advantage of inactivated vaccines?

A

Safety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Why do inactivated vaccines induce poor CD8+ T-cell responses?

A

No endogenous production of proteins -> no presentation on MHCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the disadvantages of inactivated vaccines? (3)

A
  1. Usually multiple doses required
  2. Short-lasting immunity
  3. Poor induction of CD8+ T-cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

In which settings is the lack of CD8+ T-cells induction by a vaccine problematic, and in which cases isn’t it?

A

Problematic in case of intracellular pathogens, but not a problem in case of extracellular pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is an additional rare disadvantages of inactivated vaccines? In which virus families does it occur?

A

Risk of priming for advanced disease in paramyxoviruses & feline coronavirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the two manufacturing options to manufacture subunit vaccines? Are they both in use?

A
  1. Non-recombinant: fractionation of pathogen & purification of proteins
  2. Recombinant: express gene of interest in yeasts/bacteria/cells & purification of proteins

Nearly all subunit vaccines are produced using recombinant techniques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are examples of current subunit vaccines? (3)

A
  1. Influenza
  2. Hepatitis B (HBV)
  3. Tetanus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which antigens are typically used in subunit vaccines?

A

Capsid- or membrane proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the advantages of subunit vaccines? (3)

A
  1. Safe
  2. Selection of subunits facilitates a targeted immune response
  3. Can be used as a marker vaccine to differentiate infected from vaccinated animals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are disadvantages of subunit vaccines? (3)

A
  1. Poorly immunogenic
  2. Short-lasting immunity
  3. Poor induction of CD8+ T-cell responses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Why do subunit vaccines induce poor CD8+ T-cell responses?

A

No endogenous production of proteins -> no presentation on MHCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are solutions for the poor immunogenicity of subunit vaccines? (2)

A
  1. Multiple doses
  2. Addition of adjuvants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is DIVA?

A

Differentiating vaccinated from infected animals though analyzing their immune response -> if it is only specific to vaccine components, the animal was not infected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is a virus-like particle?

A

Essentially a subunit vaccine, modified in such a way that the presentation of the subunits is virus-like -> virus-like capsid structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

By which mechanism do virus-like particles deliver antigens to cells?

A

They can infect cells, much like viruses can (they just lack the genetic material)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are examples of virus-like particle vaccines? (3)

A
  1. Hepatitis B virus (HBV)
  2. Human papilloma virus (HPV)
  3. Hepatitis E virus (HEV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are the advantages of virus-like particle vaccines? (4)

A
  1. Safe
  2. Structural similarity to viruses
  3. Selection of subunit facilitates targeted immune response
  4. Can be used as a marker vaccine to differentiate infected from vaccinated animals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are disadvantages of virus-like particle vaccines? (4)

A
  1. Poorly immunogenic
  2. Short-lasting immunity
  3. Poor induction of CD8+ T-cell responses
  4. Pre-existing immunity to VLP vector
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Why do virus-like particle vaccines induce poor CD8+ T-cell responses?

A

No endogenous production of proteins -> no presentation on MHCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Why is pre-existing immunity to VLP-vectors a problem for virus-like particle vaccines?

A

Immunity to the vector could neutralize the particles before they have a change to deliver their antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

In what configuration is the DNA in DNA vaccines stored?

A

Bacterial plasmid DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is the mechanism of action of DNA vaccines?

A

DNA gets taken up by host cells and causes transient expression of encoded genes & proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

True or false: DNA vaccines are currently used in humans

A

False; they have proven poorly immunogenic in humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

In which settings can DNA vaccines sometimes be effective in humans?

A

In heterologous prime-boost settings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

In which settings have DNA vaccines proven to be effective on their own?

A

For vaccination of small laboratory animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is the major challenge of DNA vaccines?

A

Administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What are currently explored administration methods for DNA vaccines? (4)

A
  1. Gene gun
  2. Microneedles
  3. Gas injectors
  4. In vivo electroporation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What is ‘gene gun’ administration?

A

Intradermal administration of DNA-coated gold particles

44
Q

What are the advantages of DNA vaccines? (5)

A
  1. Easy to produce
  2. Induction of humoral immune responses
  3. Induction of CD4+ and CD8+ responses
  4. Very stable -> can be stored at room temperature
  5. Can encompass large inserts
45
Q

Why do DNA viruses induce CD8+ T-cells?

A

They lead to endogenous production of antigens, which are presented on MHCI

46
Q

What are disadvantages of DNA vacciness? (2)

A
  1. Often poor protection
  2. Perceived risk of genome integration by the public
47
Q

Which two types of RNA vaccines can be distinguished?

A
  1. Non-replicating mRNA
  2. Viral-derived self-amplifying mRNA (SAM)
48
Q

What is the configuration of RNA in non-replicating mRNA vaccines?

A

Replicates human mRNA: gene of interest, flanking untranslated regions, 5’-cap and poly(A)-tail

49
Q

What is the configuration of RNA in viral-derived self-amplifying (SAM) mRNA vacciness?

A

Alphavirus mRNA structures added to region of interest, allowing for replication of mRNA

50
Q

What is the advantage of viral-derived self-amplifying mRNA vaccines (SAM) over standard mRNA vaccines?

A

Large amount of antigen production from an extremely small dose of vaccine

51
Q

How is RNA in RNA vaccines delivered intracellularly?

A

With lipid nanoparticles

52
Q

What are the advantages of RNA vaccines? (5)

A
  1. Safe
  2. Good induction of cellular immune responses, including CD8+
  3. Good induction of humoral immune response
  4. Can be administered repeatedly without immunity to administration mechanism
  5. Scalable
53
Q

What is the main disadvantage of all RNA vaccines?

A

Stability -> require cold-chain

54
Q

What are disadvantages specific to self-amplifying viral-mRNA (SAM) vaccines? (2)

A
  1. Size constraints
  2. dsRNA formation
55
Q

Why is dsRNA formation in self-amplifying viral-mRNA (SAM) vaccines disadvantageous?

A

dsRNA = potent TLR trgger -> can cause side effects

Sidenote: this can also be beneficial to inuce a strong immune response

56
Q

True or false: DC vaccines are currently being used to vaccinate against rare infectious diseases

A

False: DC vaccination is fully experimental

57
Q

What is the process of DC vaccine manufacturing? (4)

A
  1. Isolate PBMCs
  2. Select monocytes & culture into DCs
  3. Maturate DCs & expose them to antigen
  4. Re-infuse loaded DCs
58
Q

What are advantages of DC vaccines? (2)

A
  1. Good induction of cellular immune responses, including CD8+
  2. Individual, tailor-made vaccines
59
Q

What is the main disadvantage of DC vaccines? Why? (2)

A

Individual, tailor-made vaccine
1. Labour-intensive
2. Expensive

60
Q

What is a viral vector?

A

Tool used by molecular biologists to deliver genetic material into cells/hosts

61
Q

What is a viral vector-based vaccine?

A

Use of vectors to carry selected genes from another pathogen for immunization purposes

62
Q

What is the immunological advantage of vector-based vaccines?

A

They form their own adjuvant & induce a natural type of immune response

63
Q

For which disease are vector-based vaccines currently in use?

A

Covid-19 (Johnson & Johnson, University of Oxford-Astrazeneca)

64
Q

For which disease are RNA vaccines currently in use?

A

Covid-19 (Moderna, Pfizer-BioNTech)

65
Q

What are the advantages of vector-based vaccines? (4)

A
  1. Safe
  2. Intrinsic adjuvant
  3. Induction of natural immunity, including CD8+
  4. Can be used as marker vaccine to differentiate infected from vaccinated animals
66
Q

What are the disadvantages of vector-based vaccines? (2)

A
  1. Usually multiple doses required
  2. Pre-existing immunity against the vector
67
Q

What is the problem with repeated adminstration of vector-based vaccines?

A

Can lead to immunity against the vector, rather than the target of the vaccine

68
Q

What is an adjuvant?

A

Pharmacologica/immunological agent that enhances the immune response to a vaccine

69
Q

What are mechanisms of action of adjuvants? (4)

A
  1. Antigen stabilization and/or delayed release
  2. Enhanced antigen uptake in macrophages
  3. Activation of co-stimulatory molecules
  4. Improved delivery of antigens to the cytosol -> increased cross-presentation
70
Q

What are examples of adjuvants? (6)

A
  1. Aluminium salts
  2. Mineral oils
  3. Bacterial products
  4. Detergents
  5. ISCOMS
  6. Cytokines
71
Q

What are bacterial products that are frequently used as adjuvants? (2)

A
  1. Pertussis
  2. Freund’s adjuvant
72
Q

What is the disadvantage of using adenoviruses as a vector for vaccines?

A

Adenoviruses are common in humans -> there is a lot of pre-existing immunity against adenovirus

73
Q

What are workarounds of the high pre-existing immunity to adenoviruses when using them as vaccine vectors? (2)

A
  1. Picking a serotype taht is uncommon in humans
  2. Use a non-human adenovirus
74
Q

What are the currently approved SARS-CoV-2 vaccine platforms? (4)

A
  1. Inactivated virus
  2. mRNA
  3. Viral vector
  4. Protein subunit
75
Q

Which SARS-CoV-2 vaccines make use of inactivated virus? (3)

A
  1. Sinovac
  2. Sinopharm
  3. Bharat
76
Q

Which SARS-CoV-2 vaccines make use of mRNA? (2)

A
  1. Pfizer-BioNTech
  2. Moderna
77
Q

Which SARS-CoV-2 vaccines make use of viral vectors? (2)

A
  1. University of Oxford-AstraZeneca
  2. Johnson & Johnson
78
Q

Which SARS-CoV-2 vaccine makes use of protein subunits?

79
Q

What is the common target antigen of all SARS-CoV-2 vaccines?

A

Spike protein

80
Q

What is “vaccine effectiveness”? (definition)

A

Ability to protect an individual or population from an infectious disease

81
Q

What is “vaccine efficacy”? (definition)

A

Protection offered by vaccines in ideal-world settings (=clinical trials)

82
Q

When comparing mRNA and vector-based vaccines for SARS-CoV-2, which has higher efficacy?

A

mRNA has higher efficacy

83
Q

How can the lower efficacy of vector-based SARS-CoV-2 (when compared to mRNA) be offset?

A

By boosting

84
Q

Which groups of vectors influence vaccine effectiveness? (5)

A
  1. Host factors
  2. Demographic factors
  3. Vaccine access factors
  4. Immune factors
  5. Viral variant factors
85
Q

Which host factors can positively/negatively/both affect vaccine effectiveness? (5)

A

Positively: previous infection

Negatively:
-Old age
-Immune compromised
-Underlying health conditions

Both: genetic polymorphisms

86
Q

Which demographic can positively/negatively/both affect vaccine effectiveness? (4)

A

Positively:
-High levels of vaccine uptake
-High levels of herd immunity

Negatively:
-High levels of circulating virus
-Close proximity of people living together

87
Q

Which vaccine access factors can positively/negatively/both affect vaccine effectiveness? (6)

A

Negatively:
-Limited access to vaccines

Both:
-Type of vaccine used
-Number of doses
-Timing between doses
-Heterologous prime-boost
-Cost-benefit decision by national vaccine bodies

88
Q

Which immune factors can positively/negatively/both affect vaccine effectiveness? (3)

A

Positively:
-High antibody titres
-High quality of antibodies (neutralization)

Both: T-cell response

89
Q

Which viral variant factors can positively/negatively/both affect vaccine effectiveness? (2)

A

Negatively:
-Antigenic mismatch with vaccine
-Increased transmissibility

90
Q

What is “immunogenicity” of a vaccine? (definition)

A

The ability of a vaccine to stimulate an immune response to the vaccine product

91
Q

Why are immunogenicity studies of vaccines important? (3)

A
  1. Easy & high-throughput read-out in smaller numbers of patients (compared to clinical trials)
  2. Improving vaccine formulations when the immune response is not as desired
  3. Adaptation of vaccination policies
92
Q

What is a correlate of protection? (definition)

A

Immune response a vaccine/natural infection needs to induce protection from the infectious disease in the future

93
Q

What is the most frequent assay to test correlates of protection?

A

Neutralization assays using antibodies

94
Q

What is the new strategy to study correlates of protection?

A

Establishing immune profiles of protection -> trying to correlate a broad set of immunological characteristics to protection against disease

95
Q

Which immunological factors can be analysed to obtain immune profiles of protection? (8)

A

Humoral immunity:
1. Virus neutralization
2. Macrophage phagocytosis (Fc-mediated)
3. Neutrophil activation (Fc-mediated)
4. Complement deposition (Fc-mediated)
5. Antibody-dependent cellular cytotoxicity (Fc-mediated)

Cellular immunity:
6. CD4 T-cell regulation of the immune response
7. CD4 T-cell capacity to activate & induce class switch in B-cells
8. CD8 T-cell capacity to lyse virus-infected cells

96
Q

True of false: the difference in antibody titres between mRNA and adeno-based SARS-CoV-2 vaccines directly correlates to the difference in efficacy

A

False: while the adeno-based vaccines had lower antibody titres, their efficacy was relatively comparable with mRNA-based vaccines

97
Q

What are the differences between mRNA and adeno-based SARS-CoV-2 vaccines when it comes to:
1. Antibody titres
2. T-cell responses

A

Antibody titres: mRNA vaccines have higher titres & longer persistence of antibodies

T-cell responses: mRNA vaccines induce a higher number of spike-specific T-cells

98
Q

Does the humoral or cellular response suffer more from antigenic variation of viruses?

A

Humoral response

99
Q

Why does the humoral response suffer more from antigenic variation than cellular responses?

A

Antibodies recognize 3D structures -> more sensitive to antigenic variation
T-cell recognize nonamers/decamers -> less sensitive to antigenic variation

100
Q

What is a possible solution to antigenic variation?

A

Bivalent vaccination -> include multiple variants in vaccines

101
Q

What is the downside of bivalent vaccination?

A

Leads to a disproportionate boosting of the original vaccine, but does not lead to a substantial response to the new variant

102
Q

What is a problem of the current method of measuring correlates of protection of vaccines?

A

They are measured in circulation -> not representative for location where pathogens are encountered

103
Q

What is a strategy to induce local immune responses that is currently being explored for SARS-CoV-2?

A

Step 1: induce systemic immunity with intramuscular injectoin
Step 2: boost with mucosal vaccine to attract immune cells to pathogen entry sites

104
Q

What is the advantage of heterologous prime-boosting for SARS-CoV-2?

A

Leads to superior boosting of antibody and T-cell responses compared with homologous boosting

105
Q

Prior SARS-CoV-2 infection gives a [weaker/stronger] vaccination response

A

(Far) stronger

106
Q

What is the influence of age on mRNA SARS-CoV-2 vaccines?

A

No strong influence

107
Q

What is the influence of age on inactivated/adeno-based SARS-CoV-2 vaccines?

A

Less effective in elderly